TEK and acute kidney injury: It remains plausible that the subset of patients identified by the PERSEVERENCE SA-AKI prediction model may have a biological predilection to respond to microvascular stabilizing therapies, including rhTM, that seek to restore the balance between Angpt-2/Tie-2 and improve endothelial barrier function.